X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (106) 106
female (70) 70
male (69) 69
infectious diseases (63) 63
adult (62) 62
hiv infections - drug therapy (49) 49
virology (45) 45
middle aged (44) 44
immunology (40) 40
index medicus (38) 38
anti-hiv agents - therapeutic use (34) 34
hiv infections - virology (34) 34
hiv (33) 33
microbiology (26) 26
antiretroviral therapy (25) 25
infection (25) 25
viral load (25) 25
antiretroviral therapy, highly active (23) 23
pharmacology & pharmacy (23) 23
hiv infection (22) 22
cd4 lymphocyte count (20) 20
hiv infections - immunology (19) 19
protease inhibitors (19) 19
drug therapy, combination (18) 18
hiv-1 - drug effects (17) 17
hiv-1 - genetics (17) 17
genotype (16) 16
hiv infections - complications (16) 16
hiv-1 (16) 16
treatment outcome (16) 16
aged (15) 15
cohort studies (15) 15
highly active antiretroviral therapy (15) 15
risk factors (15) 15
hiv-1-infected patients (14) 14
virus diseases (14) 14
active antiretroviral therapy (13) 13
haart (13) 13
italy (13) 13
anti-hiv agents - administration & dosage (12) 12
human immunodeficiency virus--hiv (12) 12
antiviral agents (11) 11
efavirenz (11) 11
human-immunodeficiency-virus (11) 11
research (11) 11
retrospective studies (11) 11
drug therapy (10) 10
hiv infections - blood (10) 10
infected patients (10) 10
therapy (10) 10
adolescent (9) 9
disease (9) 9
health aspects (9) 9
hiv patients (9) 9
hiv-1 - isolation & purification (9) 9
infections (9) 9
pharmacokinetics (9) 9
prospective studies (9) 9
rna, viral - blood (9) 9
antiretroviral drugs (8) 8
care and treatment (8) 8
drug resistance (8) 8
hiv-infected patients (8) 8
mutation (8) 8
polymerase chain reaction (8) 8
prevalence (8) 8
ritonavir - therapeutic use (8) 8
tenofovir (8) 8
aids (7) 7
antiretroviral therapy, highly active - methods (7) 7
dna, viral - genetics (7) 7
drug administration schedule (7) 7
genetic aspects (7) 7
immunodeficiency-virus type-1 (7) 7
lamivudine (7) 7
longitudinal studies (7) 7
medicine (7) 7
neurology (7) 7
neurosciences (7) 7
stavudine (7) 7
young adult (7) 7
acquired immune deficiency syndrome--aids (6) 6
acquired immunodeficiency syndrome - drug therapy (6) 6
adenine - analogs & derivatives (6) 6
adenine - therapeutic use (6) 6
anti-hiv agents - adverse effects (6) 6
atazanavir (6) 6
benzoxazines (6) 6
cerebrospinal fluid (6) 6
combination (6) 6
cross-sectional studies (6) 6
didanosine - therapeutic use (6) 6
disease progression (6) 6
drug resistance, viral - genetics (6) 6
efficacy (6) 6
emtricitabine (6) 6
genotypes (6) 6
hepacivirus - genetics (6) 6
hepatitis c, chronic - drug therapy (6) 6
hiv infections - diagnosis (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2006, Volume 42, Issue 3 Suppl 1, pp. S23 - S24
Preliminary results from a phase II REMUNE study in four clinical centers were presented to stimulate HIV-specific immunity and potentially delay disease... 
Antiviral agents | Immunology | Research | HIV infection
Journal Article
Frontiers in Psychology, ISSN 1664-1078, 08/2019, Volume 10
ObjectiveTo study the emotional state of cognitively impaired patients through the color choice preference in a group of Alzheimer’s disease (AD) patients and... 
Lüscher color test | dementia | mild cognitive impairment | color preference | Alzheimer’s disease | personality
Journal Article
PLoS Genetics, ISSN 1553-7390, 07/2011, Volume 7, Issue 7, p. e1002173
Journal Article
Neurological Sciences, ISSN 1590-1874, 05/2018, Volume 39, Issue 5, pp. 851 - 855
To study human figure drawing in a group of Alzheimer's disease (AD) patients and compare it with a group of patients with mild cognitive impairment (MCI) and... 
Aging | Personality | Alzheimer’s disease | Mild cognitive impairment | Human figure drawing | Dementia | Body height | Neurodegenerative diseases | Alzheimers disease | Alzheimer's disease | Cognitive ability
Journal Article
by Bertoli, Ada and Sorbo, Maria Chiara and Aragri, Marianna and Lenci, Ilaria and Teti, Elisabetta and Polilli, Ennio and Di Maio, Velia Chiara and Gianserra, Laura and Biliotti, Elisa and Masetti, Chiara and Magni, Carlo F and Babudieri, Sergio and Nicolini, Laura A and Milana, Martina and Cacciatore, Pierluigi and Sarmati, Loredana and Pellicelli, Adriano and Paolucci, Stefania and Craxì, Antonio and Morisco, Filomena and Palitti, Valeria Pace and Siciliano, Massimo and Coppola, Nicola and Iapadre, Nerio and Puoti, Massimo and Rizzardini, Giuliano and Taliani, Gloria and Pasquazzi, Caterina and Andreoni, Massimo and Parruti, Giustino and Angelico, Mario and Perno, Carlo Federico and Cento, Valeria and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Baldanti, Fausto and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Bruzzone, Bianca and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Leonardis, Francesco and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Gasbarrini, Antonio and Ghisetti, Valeria and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Landonio, Simona and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Melis, Michela and Menzaghi, Barbara and Meregalli, Elisa and Micheli, Valeria and Niero, Fosca and Paoloni, Maurizio and Pieri, Alessandro and Rendina, Maria and Romagnoli, Dante and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and Zazzi, Maurizio and Hcv Virology Italian Resistance Ne and HCV Virology Italian Resistance Network (VIRONET-C)
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 8988 - 11
Natural resistance-associated substitutions (RASs) are reported with highly variable prevalence across different HCV genotypes (GTs). Frequency of natural RASs... 
GLECAPREVIR | TREATMENT-NAIVE | REAL-LIFE | PIBRENTASVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | SIMEPREVIR PLUS SOFOSBUVIR | RESPONSE RATES | DIRECT-ACTING ANTIVIRALS | 1 INFECTION | OPEN-LABEL | Hepatitis C | Disease resistance | Genotypes
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181433
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, p. e27349
Background: In HIV-infected individuals, mechanisms underlying unsatisfactory immune recovery during effective combination antiretroviral therapy (cART) have... 
CELL RECOVERY | SUBTYPES | COUNT RECOVERY | BIOLOGY | RECEPTOR | AIDS | PROGRESSION | HIV Infections - genetics | Humans | Middle Aged | Genotype | Male | CD4 Lymphocyte Count | HLA Antigens - genetics | Viral Load | HIV Infections - immunology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Cohort Studies | Antiviral agents | Care and treatment | HLA histocompatibility antigens | HIV patients | Disease susceptibility | Research | T cells | HIV (Viruses) | Genetic polymorphisms | Highly active antiretroviral therapy | Histocompatibility antigens | Analysis | Genetic aspects | HIV infection | Haplotypes | Therapy | Laboratories | Genes | Immunoglobulin-like receptors | Infections | Lymphocytes T | Gene polymorphism | Recovery | Confidence intervals | Hepatitis | Receptors | Immunology | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Drug therapy | Genotypes | Killing | Antiretroviral drugs | Immunoglobulins | Immune response | Internal medicine | Potassium channels (inwardly-rectifying) | Latent infection | Risk reduction | Patients | Antiretroviral therapy | CD4 antigen | Polymerase chain reaction | White blood cells | Medicine | Infectious diseases | Hospitals | Genotyping | Gene frequency | Ligands | Histocompatibility antigen HLA | Polymorphism | Acquired immune deficiency syndrome | HIV | Human immunodeficiency virus
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2012, Volume 17, Issue 6, pp. 1011 - 1020
Background: The aim of this study was to investigate the effect on fasting lipid parameters of switching to tenofovir disoproxil fumarate (TDF) plus... 
ABACAVIR | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | TENOFOVIR DF | RISK | ANTIRETROVIRAL THERAPY | HIV-1-INFECTED PATIENTS | IMPACT | VIROLOGY | EFAVIRENZ | PHARMACOLOGY & PHARMACY | RANDOMIZED COMPARATIVE TRIAL | DYSLIPIDEMIA
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e47485
Background: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to... 
POTENT ANTIRETROVIRAL THERAPY | VIRUS TYPE-1 REPLICATION | CLINICAL-TRIAL | DIDANOSINE | MULTIDISCIPLINARY SCIENCES | T-CELL-ACTIVATION | HYDROXYUREA | HIV-1-INFECTED INDIVIDUALS | INFECTED PATIENTS | PLACEBO-CONTROLLED TRIAL | COMBINATION | Anti-HIV Agents - pharmacology | Deoxyadenine Nucleotides - metabolism | Didanosine - therapeutic use | Immunomodulation - drug effects | Humans | Didanosine - pharmacology | Male | Viral Load | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - growth & development | Dideoxynucleotides - metabolism | Urea - analogs & derivatives | Placebos | Adult | Anti-HIV Agents - therapeutic use | Female | CD4-Positive T-Lymphocytes - virology | Biomarkers - metabolism | Double-Blind Method | Drug Administration Schedule | HIV-1 - drug effects | HIV Infections - virology | RNA, Viral - biosynthesis | CD4 Lymphocyte Count | HIV-1 - immunology | Urea - therapeutic use | Analysis of Variance | HIV Infections - drug therapy | RNA, Viral - drug effects | Delayed-Action Preparations | CD4-Positive T-Lymphocytes - drug effects | Drug Combinations | Urea - pharmacology | Antiviral agents | Immune response | RNA | Analysis | Dosage and administration | Research | Drug therapy | HIV infection | Therapy | Toxicity | Clinical trials | Viruses | Infections | Activation | Lymphocytes T | Cell activation | Randomization | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiviral activity | Drug dosages | Chronic illnesses | Immune system | Antiretroviral drugs | RNA viruses | Markers | Ribonucleic acid--RNA | Disease control | Variance analysis | Morbidity | Constraining | CD4 antigen | Virology | Studies | Infectious diseases | Adults | Didanosine | Viral infections | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2015, Volume 72, pp. 114 - 118
Journal Article
Atherosclerosis, ISSN 0021-9150, 2017, Volume 263, pp. 398 - 404
Abstract Background and aims PREVALEAT (PREmature VAscular LEsions and Antiretroviral Therapy) II is a multicenter, longitudinal cohort study aimed at the... 
Cardiovascular | Atazanavir | HIV | Darunavir | Efavirenz | Cardiovascular risk | Atherosclerosis | CARDIAC & CARDIOVASCULAR SYSTEMS | ADULTS | ENDOTHELIAL FUNCTION | PROTEASE INHIBITORS | LESIONS | CAROTID VESSELS | DISEASE | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | MEDIA THICKNESS | IMMUNODEFICIENCY | Multivariate Analysis | Predictive Value of Tests | Humans | Middle Aged | Male | Vasodilation | Time Factors | HIV Infections - diagnosis | Lipids - blood | Cardiovascular Diseases - diagnostic imaging | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Brachial Artery - physiopathology | Female | Odds Ratio | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Carotid Intima-Media Thickness | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Endothelium, Vascular - physiopathology | Inflammation Mediators - blood | Treatment Outcome | CD4 Lymphocyte Count | Biomarkers - blood | Chi-Square Distribution | Benzoxazines - therapeutic use | Atazanavir Sulfate - therapeutic use | HIV Infections - complications | HIV Infections - drug therapy | Italy | Darunavir - therapeutic use | Longitudinal Studies | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Communicable diseases | HIV patients | Comparative analysis | Cardiovascular diseases | HIV (Viruses) | HIV infection | Risk factors | Low density lipoproteins | Triglycerides | Protease inhibitors | Proteases | Blood lipids
Journal Article